An Australian stem cell and regenerative medicine company

ASX Announcements

30 Nov 2015 Expiry of Unlisted Options
10 Nov 2015 Results of Annual General Meeting
05 Nov 2015 Restricted Securities to be Released from Escrow
04 Nov 2015 Cynata Engages CRO to Conduct GvHD Clinical Trial
13 Oct 2015 CYP in Major New Collaboration for Cell Therapy for Cancer
05 Oct 2015 Notice of Annual General Meetin/Proxy Form
06 Sep 2015 Cynata to Present at Rodman & Renshaw Investment Conference
02 Sep 2015 SeeThruEquity Initiates Cynata Research Coverage
20 Aug 2015 Appendix 4G
29 Jul 2015 Cynata in Heart Disease Collaboration with Uni of Sydney
16 Jul 2015 Information Required Under Listing Rule 3.10.5A
16 Jul 2015 Appendix 3B
14 Jul 2015 Section 708A Notice
14 Jul 2015 Private Placement to US Institutional Investors Completed
24 May 2015 R&D Tax Incentive
20 May 2015 Cynata-Cymerus Progress Report
07 May 2015 ASX Price Query
29 Mar 2015 Appendix 3Y-John Chiplin
17 Mar 2015 Cynata CEO to Chair World Congress Session on Stem Cells
15 Mar 2015 Appendix 3Y-Stewart Washer
15 Mar 2015 Executive Services Contracts Renewed/Vesting Conditions Met
11 Mar 2015 Commences Further Stage of Stem Cell Manufacturing Program
05 Mar 2015 Director Options Vesting Condition Met
04 Mar 2015 Cynata Presenting at 8th Annual ASX Spotlight New York 2015
19 Feb 2015 BBY Updates Cynata Research Coverage
18 Feb 2015 Cynata Achieves Major Stem Cell Manufacturing Milestone
16 Feb 2015 Trading Halt
15 Feb 2015 Cynata Engages CRO to Plan Clinical Trial
12 Feb 2015 Change of Share Registry
11 Feb 2015 Cynata Engages Leading US Investor Relations Firm
02 Feb 2015 Cynata Partners with University of Western Australia
14 Jan 2015 Top 20 Shareholders
13 Jan 2015 Section 708A Notice
13 Jan 2015 Appendix 3B
05 Jan 2015 Section 708A Notice
05 Jan 2015 Completion of Exercise of Underwritten Listed Options
30 Dec 2014 Section 708A Notice
30 Dec 2014 Appendix 3B-Exercise of Listed Options
23 Dec 2014 Section 708A Notice
23 Dec 2014 Appendix 3B-Exercise of Listed Options
17 Dec 2014 Appendix 3Y-Peter Webse
17 Dec 2014 Section 708A Notice
17 Dec 2014 Appendix 3B-Exercise of Listed Options
10 Dec 2014 Section 708A Notice
10 Dec 2014 Appendix 3B-Exercise of Listed Options
04 Dec 2014 Section 708A Notice
04 Dec 2014 Appendix 3B-Exercise of Listed Options
03 Dec 2014 CYP to Present at Major International Stem Cell Conference
30 Nov 2014 Notification of Expiry of Listed Options
24 Nov 2014 Cynata Listed Options Fully Underwritten